ICD10 code of Intracranial Hypertension and ICD9 code

The ICD-10-CM code for Idiopathic Intracranial Hypertension (IIH), often referred to as Pseudotumor Cerebri, is G93.2, while the corresponding ICD-9-CM code is 348.2. These billing and diagnostic codes are essential for healthcare providers to document the condition, which involves elevated intracranial pressure without an intracranial mass or infection.

What is the clinical significance of Intracranial Hypertension coding?

In clinical practice, Intracranial Hypertension is frequently documented using the code G93.2. Accurate coding is vital because it facilitates insurance coverage for necessary interventions, such as neurosurgical shunts or venous sinus stenting, and ensures that patients are correctly tracked within electronic health records. Because Intracranial Hypertension mimics the symptoms of a brain tumor—including papilledema, severe headaches, and pulsatile tinnitus—precise coding helps clinicians distinguish this condition from secondary causes of elevated intracranial pressure, such as obstructive hydrocephalus or cerebral venous sinus thrombosis.

How do medical professionals diagnose Intracranial Hypertension?

Diagnosis of Intracranial Hypertension is typically confirmed through a combination of neuroimaging and lumbar puncture. The Modified Dandy Criteria are often utilized to establish a formal diagnosis. Clinicians must rule out secondary causes before confirming a diagnosis of idiopathic Intracranial Hypertension. Common diagnostic steps include:

• Magnetic Resonance Imaging (MRI/MRV): To rule out structural lesions or venous sinus thrombosis.


• Lumbar Puncture (LP): To measure the opening pressure of the cerebrospinal fluid (CSF), typically confirming an elevated pressure (usually >25 cm H2O in adults).


• Ophthalmological Evaluation: A comprehensive eye exam to assess for papilledema (swelling of the optic nerve) and monitor for vision loss.


• Neurological Exam: To assess for cranial nerve palsies, such as double vision (diplopia).

What are the primary treatment pathways for Intracranial Hypertension?

Once a diagnosis is confirmed and coded, management of Intracranial Hypertension focuses on preserving vision and alleviating debilitating symptoms. Treatment is highly individualized and may include pharmacological management with acetazolamide (a diuretic) to reduce CSF production. If medical therapy is insufficient or if there is rapid vision deterioration, neurosurgical intervention may be required. Currently, 2,580 people with Intracranial Hypertension have joined the DiseaseMaps community, sharing their unique journeys with these treatments, ranging from frequent lumbar punctures to permanent shunt placement or stent surgery.

How does Intracranial Hypertension impact daily life?

Living with Intracranial Hypertension presents significant challenges, as the condition affects both the nervous system and the digestive system, frequently causing nausea, vomiting, and chronic fatigue. The emotional burden of managing a condition that causes chronic pain, insomnia, and the constant fear of vision loss cannot be overstated. Clinical psychologists emphasize that patients with Intracranial Hypertension often benefit from support networks that validate their experience, as the "invisible" nature of the disease can lead to isolation.

Next steps

• Consult with a neurologist or neuro-ophthalmologist to review your specific diagnostic criteria and ICD-10 documentation.


• Monitor your vision regularly with a comprehensive eye exam to ensure that intracranial pressure is not causing permanent damage to the optic nerve.


• Join the Intracranial Hypertension community on DiseaseMaps.org to connect with others who have navigated the complexities of diagnosis and treatment.


• Keep a symptom log of headaches, visual changes, and tinnitus to share with your medical team during follow-up appointments.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• National Institute of Neurological Disorders and Stroke (NINDS): Idiopathic Intracranial Hypertension Information Page.


• Orphanet: Rare Disease Database (ORPHA: 68388).


• NIH Genetic and Rare Diseases (GARD) Information Center: Pseudotumor Cerebri.


• OMIM (Online Mendelian Inheritance in Man): Entry #605702.